VAERS 2603724
GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLULAVAL QUADRIVALENT) · Charge 9NF5N
- Staat
- GA
- Alter
- 9,0
- Geschlecht
- F
- Eingang
- 25.03.2023
- Impfdatum
- 21.02.2023
- Beginn
- 18.03.2023
- Tage bis Beginn
- 25,0
- Dosis
- UNK
- Route/Site
- - / -
Symptomtext
Developed diffuse vesicular rash, that was VZV PCR positive c/w Chicken Pox Disease. Extended hospitalization stay which had been for the management of TB pulmonary infection (approximately an additional 1 week) to receive IV therapy (acyclovir), developed an infiltration while on therapy requiring antidote administration. Plan to complete total 14 day course of acyclovir/valtrex pending rash improvement.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash vesicular
- Hospital-Tage
- 7,0
- Labordaten
- + VZV PCR on 3/20/23
- Aktuelle Erkrankungen
- At time of vaccination, patient had HIV and TB pulmonary infection, but it was unknown at that time to that provider who recommended vaccination
- Vorgeschichte
- See Item 11
- Andere Medikamente
- Unknown
- Allergien
- Unknown
- Vorherige Impfungen
- -